Literature DB >> 2914525

Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery.

P J McDonald1, V W Fazio, R G Farmer, D G Jagelman, I C Lavery, W B Ruderman, K A Easley, P H Harper.   

Abstract

Four hundred eighty-six patients who have had resections for Crohn's disease at the Cleveland Clinic were reviewed. The patients were categorized by indication for surgery into three groups: perforating (P) (135 patients), nonperforating (NP) (278 patients), and miscellaneous (M) (77) patients. One hundred ninety-four patients had two or more resections and 56 underwent a third resection. Patients were no more likely to have the same indication for surgery at the time of the second resection (P = 25 percent; NP = 44 percent; M = 57 percent) or the third resection (P = 11 percent; NP = 65 percent; M = 55 percent). There was also no difference in the interval between resections for the P and NP groups. The lack of agreement between resections suggests that the categorization of patients into P and NP groups does not facilitate prediction of the nature of recurrent disease. The concept of aggressive perforating and indolent nonperforating Crohn's is not substantiated by this study.

Entities:  

Mesh:

Year:  1989        PMID: 2914525     DOI: 10.1007/BF02553823

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

Review 1.  Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

Authors:  J P Achkar; B Shen
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  Predicting, treating and preventing postoperative recurrence of Crohn's disease: the state of the field.

Authors:  Anna M Borowiec; Richard N Fedorak
Journal:  Can J Gastroenterol       Date:  2011-03       Impact factor: 3.522

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

4.  Early re-laparotomy for post-operative complications is a significant risk factor for recurrence after ileocaecal resection for Crohn's disease.

Authors:  Thilo Welsch; Ulf Hinz; Thorsten Löffler; Gregor Muth; Christian Herfarth; Jan Schmidt; Peter Kienle
Journal:  Int J Colorectal Dis       Date:  2007-03-28       Impact factor: 2.571

5.  Crohn's disease severity in familial and sporadic cases.

Authors:  F Carbonnel; G Macaigne; L Beaugerie; J P Gendre; J Cosnes
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 6.  Factors affecting recurrence after surgery for Crohn's disease.

Authors:  Takayuki Yamamoto
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 7.  Postsurgical recurrence of ileal Crohn's disease: an update on risk factors and intervention points to a central role for impaired host-microflora homeostasis.

Authors:  Michael F Cunningham; Neil G Docherty; J Calvin Coffey; John P Burke; P Ronan O'Connell
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

8.  Reoperative inflammatory bowel disease surgery.

Authors:  Rowena L Ramirez; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2006-11

9.  The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease.

Authors:  S Post; C Herfarth; E Böhm; G Timmermanns; H Schumacher; G Schürmann; M Golling
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

10.  On the etiology of Crohn disease.

Authors:  D Mishina; P Katsel; S T Brown; E C Gilberts; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.